DrugPatentWatch Database Preview
PROAIR RESPICLICK Drug Profile
» See Plans and Pricing
When do Proair Respiclick patents expire, and when can generic versions of Proair Respiclick launch?
Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. There are fifteen patents protecting this drug.
This drug has three hundred patent family members in thirty-one countries.
The generic ingredient in PROAIR RESPICLICK is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Proair Respiclick
A generic version of PROAIR RESPICLICK was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
Summary for PROAIR RESPICLICK
| International Patents: | 300 |
| US Patents: | 15 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 61 |
| Patent Applications: | 4,118 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PROAIR RESPICLICK |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PROAIR RESPICLICK |
| What excipients (inactive ingredients) are in PROAIR RESPICLICK? | PROAIR RESPICLICK excipients list |
| DailyMed Link: | PROAIR RESPICLICK at DailyMed |
Pharmacology for PROAIR RESPICLICK
| Drug Class | beta2-Adrenergic Agonist |
| Mechanism of Action | Adrenergic beta2-Agonists |
US Patents and Regulatory Information for PROAIR RESPICLICK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROAIR RESPICLICK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROAIR RESPICLICK
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 8464301 | Start Trial |
| Hungary | E026806 | Start Trial |
| Poland | 2436414 | Start Trial |
| Peru | 20020075 | Start Trial |
| Japan | 5820005 | Start Trial |
| Mexico | 2017002552 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
